CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment FNF Q1 2026 Earnings EPS Falls 1095 Below Estimates as Housing Headwinds Persist Rallybio Corporation Q1 2026 Earnings Wider Loss Reflects RD Investment Stock Gains ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech RKDA Q3 2025 Earnings Stunning EPS Surprise Driven by NonRecurring Items Stock Rallies BMY Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Response